Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.
Related Research units
Abstract
Whether it is possible to reduce the intensity of treatment in early (stage I or II) Hodgkin's lymphoma with a favorable prognosis remains unclear. We therefore conducted a multicenter, randomized trial comparing four treatment groups consisting of a combination chemotherapy regimen of two different intensities followed by involved-field radiation therapy at two different dose levels.
Bibliographical data
| Original language | German |
|---|---|
| Article number | 7 |
| ISSN | 0028-4793 |
| Publication status | Published - 2010 |
| pubmed | 20818855 |
|---|
